Hikma Pharmaceuticals sell Barclays PLC
Start price
06.01.26
/
50%
€18.40
Target price
06.01.27
-
Performance (%)
-1.28%
Price
12.06.26
€17.36
Summary
This prediction is currently active. With a performance of -1.28%, the SELL prediction by Barclays_PLC is trending in the right direction. A total of €0.41 was paid as dividends for this prediction. This prediction currently runs until 06.01.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Hikma Pharmaceuticals | 2.783% | 2.783% |
| iShares Core DAX® | 0.271% | 1.796% |
| iShares Nasdaq 100 | 1.884% | 2.153% |
| iShares Nikkei 225® | 3.579% | 5.306% |
| iShares S&P 500 | 0.151% | 1.090% |
Comments by Barclays_PLC for this prediction
In the thread Hikma Pharmaceuticals diskutieren
Hikma Pharmaceuticals (OTCMKTS:HKMPF) was downgraded by analysts at Barclays PLC to an "underweight" rating.
Ratings data for HKMPF provided by MarketBeat